Nova Southeastern University Office of Academic Affairs Search NSU Site Map Nova Southeastern University
President's Faculty R & D Grant 
Home
Committees, Councils
  and Boards
Faculty Policy Manual
NSU Scholarly Journals
Professional Journals
Prof. Memberships
Academic Policies & Procedures
Provost's Research and Scholarship Award
President's Faculty
 R & D Grant
PFRDG Application Review Process by NSU Librarians
Faculty Resources
Student Resources
Contact Us

Print this page  

 


With a focus on learning, we employ a range of strategies to support innovation, collaboration across centers, and university-wide discussion and decision-making

 

Fourth Annual Grant Winners 2003-2004

Ana Maria Castejon, Ph.D., HPD College of Pharmacy

Dean William Hardigan – HPD College of Pharmacy

Title: Mechanisms of Vascular Impairment Induced by Withdrawal of Statins

Abstract:

Statins, are the most effective and widely used lipid-lowering drugs. Statins are effective in primary and secondary prevention of cardiac events in patients with ischemic heart disease. Long-term treatment with statins is commonly prescribed; however, nearly 1.2 % of subjects receiving statin treatment develop requiring therapy discontinuation complications (myopathy, rhabdomyolysis, liver dysfunction). Recent studies in patients with coronary heart disease reported that discontinuation of therapy with statins was associated with increases in thrombotic vascular events and of death or non-fatal myocardial infarction. The mechanisms underlying these effects are unknown, although impaired nitric oxide (NO) production by endothelial cells has been described after discontinuation of statins. Because of the relevance of these observations, we propose to investigate how statin withdrawal induces vascular complications. The study will be conducted in bovine endothelial cells and in vascular smooth muscle cells in culture. The effects of statin withdrawal on the production of vascular protective and vascular deleterious substances will be investigated. Specifically, we will determine the expression and levels of NO, endothelin-1 (ET-1) and of the intercellular cell adhesion molecule (ICAM-1) by the endothelium, and of angiotensin-II AT1-receptor expression in vascular smooth muscle cells. It is proposed that withdrawal of statins should lead to activation of vasoconstrictor, mitogenic and inflammatory markers (ET-1, AII, ICAM-1) and to reduction of the protective action of NO.